Ms. McCaskill has investigated, Teva, the world’s largest maker of generic drugs, and other drug manufacturers for the last 18 months to determine their roles in the opioid crisis. The Israeli company is one of the drugmakers being sued by hundreds of cities and counties in Ohio federal court.
But Mr. Johnson said he does not believe it is Congress’ duty to determine Teva’s accountability for the opioid crisis.
“I think in this case, you have active lawsuits where these issues are all being adjudicated,” said Mr. Johnson. “I don’t like competing with other committees’ jurisdictions or actions on this thing, in this case the courts. They’re going to do a really good job of discovery, and these issues will be fully vetted in the courts.”
More articles on leadership and management:
Dr. Anthony Tersigni: Innovative care models are new catalysts to transforming healthcare
Kindred, Massachusetts General Hospital to lay off 152 workers
10 thoughts on the healthcare business
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.